Bromhexine Hydrochloride Prophylaxis of COVID-19 for Medical Personnel: A Randomized Open-Label Study-center
randomized open-label study medical staff managing patients with suspected and confirmed COVID-19 were
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) FOR STROKE RECOVERYLEGG, L.A.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.A.,
DENNIS, M.,
MEAD, G.E.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J in people who were not depressed at randomisation. A large
trial of fluoxetine for stroke recovery
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) FOR STROKE RECOVERYLEGG, L.A.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.A.,
DENNIS, M.,
MEAD, G.E.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J in people who were not depressed at randomisation. A large
trial of fluoxetine for stroke recovery
Subcutaneous abatacept for the treatment of rheumatoid arthritis: Longterm data from the ACQUIRE trialE (ACQUIRE)
trial comprised a 6-month,
randomized, double-blind (DB) period, in which patients received
Cerebrolysin for acute ischaemic stroke/668 in placebo group; RR 0.97 95% CI 0.86 to 1.09,
random-effects model (3
trials, 1335 participants, moderate